Results 201 to 210 of about 966,069 (278)

Immersive Technologies for Cognitive Rehabilitation in Dementia and Mild Cognitive Impairment: Systematic Review.

open access: yesJ Med Internet Res
Konecny J   +13 more
europepmc   +1 more source

Understanding VR Accessibility Practices of VR Professionals

open access: yesProceedings of the 2025 CHI Conference on Human Factors in Computing Systems
Yi Wang   +4 more
openaire   +1 more source

SiOx‐Based Probabilistic Bits Enabling Invertible Logic Gate for Cryptographic Applications

open access: yesAdvanced Intelligent Systems, EarlyView.
To enable lightweight hardware encryption and decryption, a Ti/SiOx/Ti threshold switching device is engineered to generate controllable stochastic oscillations. By tuning the input voltage, the device produces a programmable spike probability governed by intrinsic switching dynamics, enabling probabilistic bits that construct an invertible ...
Jihyun Kim, Hyeonsik Choi, Jiyong Woo
wiley   +1 more source

Virtual Reality-Enhanced Training for Trauma-Informed Care Among Residential and Child Mental Health Professionals: Pre-Post Evaluation Study.

open access: yesJMIR Med Educ
Kostadinov K   +16 more
europepmc   +1 more source

Psychophysiological effects of traditional cycling, virtual reality-enhanced cycling, and passive virtual reality exposure in young adults: A controlled within-subject study. [PDF]

open access: yesPLoS One
Alhammad SA   +10 more
europepmc   +1 more source

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled, Phase 3 Trial

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Primary autoimmune thrombocytopenia (ITP) is characterized by thrombocytopenia, bleeding, and reduced health‐related quality of life. In the Phase 3 ADVANCE IV study, intravenous efgartigimod induced significant platelet count responses versus placebo in patients with chronic ITP. ADVANCE SC, a Phase 3, multicenter, randomized, double‐blinded,
Nichola Cooper   +546 more
wiley   +1 more source

Real‐World Outcomes of FLAG‐Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT In a large multicenter real‐world cohort, we aimed to evaluate outcomes of FLAG‐Ida salvage therapy for relapsed/refractory (R/R) acute myeloid leukemia (AML) and validated the SALFLAGE prognostic score. We analyzed 1079 adults with R/R AML treated across 112 PETHEMA institutions over 26 years (1998–2024), including patients with primary ...
Gaspar Aspas Requena   +49 more
wiley   +1 more source

Home - About - Disclaimer - Privacy